Insight Pharm Reports

Biosimilars: Surveying the Market Landscape Report - This report reviews all aspects of biosimilar production, from manufacturing and marketing to the regulatory landscape.

Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity Report

Antibody-Drug Conjugates 2011 – real breakthrough still to come: a Technology, Stakeholder and R&D Pipeline Analysis Report

Hematological Cancer Therapies: Pipelines, Markets, and Business Considerations

This Insight Pharma Report focuses on the applications, technology and market aspects of high-content analysis.

New Report on The PI3K/Akt/mTor Pathway authored by, Peter Norman, MBA, PhD

New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects

Just Published Report on Cytokine-Based Therapies and Inhibitors: R&D Pipelines, Markets, and Strategic Issues

View IPR’s Most Recent Report Titles from the 2011 Catalog and Our Newly Launched Insight Update Series.

Insight Pharma Reports Announces Next-Generation Mass Spectrometry: Technology Advances and Applications, Authored by K. John Morrow, Jr., PhD.